Dr. Desiree La Charite, MD

Dr. La Charite practices at Wellstar Kennestone Regional Medical Center in Marietta, Georgia, part of Wellstar Health System.

Dr. La Charite's NPI, 1649246570, was assigned on February 28, 2006. Dr. La Charite holds Georgia license 062132.

Dr. La Charite's primary practice is Wellstar Kennestone Regional Medical Center, at 677 Church Street, Marietta, GA 30060 in Cobb County. The practice phone is (770) 793-5000.

Dr. La Charite's primary practice is Wellstar Kennestone Regional Medical Center in Marietta, Georgia, part of Wellstar Health System. The medical group on file is Wellstar Medical Group. Dmand AI also links Dr. La Charite to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. La Charite practices, 5 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. La Charite's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dmand AI has Dr. La Charite's licenses on file in 2 states: Georgia and Wisconsin.

CMS data shows 280 Medicare services from Dr. La Charite across 3 procedure codes in 2024, for 282 Medicare patients. Medicare paid $35,045 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 282 Medicare patients who saw Dr. La Charite in 2024. The largest group is 75 to 84, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. La Charite's median patient age at 57, with 62% women.

In 2024, Dr. La Charite wrote 133 Medicare Part D claims for 96 patients. 92% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $98 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. La Charite for performance year 2024, reported through an alternative payment model (APM).

CMS Open Payments shows 9 general payments to Dr. La Charite from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 78% of the total. Bristol-Myers Squibb Company paid the most, $1,611.